Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Lymphoma, B-Cell, Marginal Zone × Pemetrexed × 90 days × Clear all

Sponsor

Conditions

Carcinoma, Non-Small-Cell Lung 90 Lung Neoplasms 34 Neoplasms 9 Neoplasm Metastasis 9 Parkinson Disease 4, Autosomal Dominant Lewy Body 7 Mesothelioma, Malignant 7 Colorectal Neoplasms 7 Carcinoma 4 Uterine Cervical Neoplasms 3 Rectal Neoplasms 3 Pancreatic Neoplasms 3 Mesothelioma 3 Colonic Neoplasms 3 Advanced Solid Tumors 3 Adenocarcinoma 3 Thoracic Neoplasms 2 Respiratory Tract Neoplasms 2 Respiratory Tract Diseases 2 Ovarian Neoplasms 2 Non-Squamous Non-small Cell Lung Cancer 2 Neoplasms by Site 2 NSCLC 2 Meningeal Carcinomatosis 2 Lung Diseases 2 Carcinoma, Pancreatic Ductal 2 Carcinoma, Bronchogenic 2 Brain Neoplasms 2 Adenocarcinoma of Lung 2 Urinary Bladder Neoplasms 1 Squamous Cell Carcinoma of Head and Neck 1

Interventions

Rituximab 19 Cyclophosphamide 13 Lenalidomide 10 zanubrutinib 8 fludarabine 8 venetoclax 5 fludarabine phosphate 5 pirtobrutinib 4 orelabrutinib 4 Vincristine 4 obinutuzumab 3 Whole-Body Irradiation 3 Specimen Handling 3 Prednisone 3 Magnetic Resonance Spectroscopy 3 Doxorubicin 3 CT-P10 3 ibrutinib 2 Therapeutics 2 Radiation 2 Mycophenolic Acid 2 Maintenance 2 Leukapheresis 2 Immunotherapy, Adoptive 2 Granulocyte Colony-Stimulating Factor 2 Cyclosporine 2 Biopsy 2 Bendamustine Hydrochloride 2 voruciclib 1 treosulfan 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡